title: Efficacy of low dose barbiturate coma therapy for the patients with intractable intracranial hypertension using the bispectral index monitoring.
abstract: OBJECTIVE
  Barbiturate coma therapy (BCT) is a useful method to control increased intracranial pressure (IICP) patients. However, the complications such as hypotension and hypokalemia have caused conditions that stopped BCT early. The complications of low dose BCT with Bispectral index (BIS) monitoring and those of high dose BCT without BIS monitoring have been compared to evaluate the efficacy of low dose BCT with BIS monitoring.
  
  
  METHODS
  We analyzed 39 patients with high dose BCT group (21 patients) and low dose BCT group (18 patients). Because BIS value of 40-60 is general anesthesia score, we have adjusted the target dose of thiopental to maintain the BIS score of 40-60. Therefore, dose of thiopental was kept 1.3 to 2.6 mg/kg/hour during low dose BCT. However, high dose BCT consisted of 5 mg/kg/hour without BIS monitoing.
  
  
  RESULTS
  The protocol of BCT was successful in 72.2% and 38.1% of low dose and high dose BCT groups, respectively. The complications such as QT prolongation, hypotension and cardiac arrest have caused conditions that stopped BCT early. Hypokalemia showed the highest incidence rate in complications of both BCT. The descent in potassium level were 0.63 +/- 0.26 in low dose group, and 1.31 +/- 0.48 in high dose group. The treatment durations were 4.89 +/- 1.68 days and 3.38 +/- 1.24 days in low dose BCT and high dose BCT, respectively.
  
  
  CONCLUSIONS
  It was proved that low dose BCT showed less severe complications than high dose BCT. Low dose BCT with BIS monitoring provided enough duration of BCT possible to control ICP.
authors.affiliation: Department of Neurosurgery, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.
authors.forename: Hung-Shik
authors.initials: HS
authors.lastname: An
authors.forename: Byung-Moon
authors.initials: BM
authors.lastname: Cho
authors.forename: Jeong-Han
authors.initials: JH
authors.lastname: Kang
authors.forename: Moon-Kyu
authors.initials: MK
authors.lastname: Kim
authors.forename: Sae-Moon
authors.initials: SM
authors.lastname: Oh
authors.forename: Se-Hyuck
authors.initials: SH
authors.lastname: Park
references.citation: Can J Neurol Sci. 1984 Nov;11(4):434-40
references.pmid: 6440704
references.citation: Crit Care. 2007;11(5):R108
references.pmid: 17897479
references.citation: J Physiol. 2007 May 15;581(Pt 1):277-89
references.pmid: 17331992
references.citation: Neurol Clin. 2008 May;26(2):521-41, x
references.pmid: 18514825
references.citation: Resuscitation. 2001 Jan;48(1):77-90
references.pmid: 11162885
references.citation: J Neurosurg. 1988 Jul;69(1):15-23
references.pmid: 3288723
references.citation: AANA J. 2001 Dec;69(6):477-83
references.pmid: 11837151
references.citation: Pediatr Crit Care Med. 2003 Jul;4(3 Suppl):S49-52
references.pmid: 12847349
references.citation: J Neurosurg. 1985 Mar;62(3):383-8
references.pmid: 3882899
references.citation: Acta Anaesthesiol Scand Suppl. 1975;57:1-17
references.pmid: 128981
references.citation: J Crit Care. 2004 Sep;19(3):174-8
references.pmid: 15484178
references.citation: J Korean Neurosurg Soc. 2008 Sep;44(3):141-5
references.pmid: 19096664
references.citation: J Neurosurg. 1979 Jan;50(1):26-30
references.pmid: 758375
references.citation: Anesthesiology. 1999 Dec;91(6):1853-60
references.pmid: 10598630
references.citation: Ther Drug Monit. 2009 Apr;31(2):153-69
references.pmid: 19177032
references.citation: Int Arch Med. 2009 Jul 31;2(1):23
references.pmid: 19646241